Publication Date: 2023-07-17
Practice Area: Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Williams
Attorneys: For plaintiff: Amy M. Dudash, Morgan, Lewis & Bockius LLP, Wilmington, DE; Amanda S. Williamson, Christopher J. Betti, Krista L. Venegas, Maria E. Doukas, Zachary Miller, Guylaine Hache, Michael T. Sikora, Morgan, Lewis & Bockius LLP, Chicago, IL; Eric Kraeutler, Morgan, Lewis & Bockius LLP, Philadelphia, PA, for plaintiff.
for defendant: Jack B. Blumenfeld, Megan E. Dellinger, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; Charles E. Lipsey, J. Derek , Ryan P. O'Quinn, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA; William B. Raich, Michael J. Flibbert, Yoonhee Kim, Yoonjin Lee, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, D.C.; Alissa K. Lipton, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Boston, MA for defendant.
Case Number: 21-1015-GBW
Claim that patent terms were indefinite due to being susceptible to multiple meanings for a POSA rejected where the scientific evidence demonstrated that a POSA would only understand the term as having one meaning, and where defendant attempted to incorporate limiting language not supported by the intrinsic record.